SAN ANTONIO--(BUSINESS WIRE)--KCI, an Acelity Company, today announced that the U.S. Food and Drug Administration (FDA) has granted the Company’s De Novo request for the PREVENA™ Incision Management ...
Research presented at the 30th American Association of Hip and Knee Surgeons Annual Meeting (AAHKS) builds on existing evidence that PREVENA™ Therapy lowers surgical site complications and readmission ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. –80 mm Hg single-use negative wound pressure therapy had ...
The PREVENA RESTOR™ Therapy portfolio optimizes post-operative care by delivering negative pressure therapy to the incision and surrounding soft tissue to enhance recovery ST. PAUL, Minn.--(BUSINESS ...
Vacuum-assisted closure (VAC) is a method of decreasing air pressure around a wound to assist the healing. It’s also referred to as negative pressure wound therapy. During a VAC procedure, a ...
ST. PAUL, Minn.--(BUSINESS WIRE)--3M today announced new data demonstrating the PREVENA™ Incision Management System significantly mitigated 90-day surgical site complications (SSCs) and readmission ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results